US Patent Issued to Industry-Academic Cooperation Foundation Gyeongsang National University on March 17 for "Composition for predicting clinical stage of alzheimer's disease and kit using the same" (South Korean Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,347, issued on March 17, was assigned to Industry-Academic Cooperation Foundation Gyeongsang National University (Jinju-si, South Korea).

"Composition for predicting clinical stage of alzheimer's disease and kit using the same" was invented by Myeong Ok Kim (Jinju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The composition for predicting Alzheimer's disease prognosis comprising a detection reagent that specifically binds to any one or more genes selected from the group consisting of Nos1 (Nitric oxide synthase 1), Aph1B (Anterior pharynx defective 1 homolog B), Ryr3 (Ryanodine receptor 3), Atf6 (Activating transcriptional factor ...